KME Stock Overview
Engages in debt portfolios management in Poland, Spain, Mexico, and the Czech Republic. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Kancelaria Medius S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | zł0.35 |
52 Week High | zł0.70 |
52 Week Low | zł0.23 |
Beta | 0.47 |
11 Month Change | 30.83% |
3 Month Change | 16.78% |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | -94.48% |
Change since IPO | 74.00% |
Recent News & Updates
Recent updates
Shareholder Returns
KME | PL Commercial Services | PL Market | |
---|---|---|---|
7D | -0.6% | 5.3% | -3.1% |
1Y | n/a | 0.05% | -1.7% |
Return vs Industry: Insufficient data to determine how KME performed against the Polish Commercial Services industry.
Return vs Market: Insufficient data to determine how KME performed against the Polish Market.
Price Volatility
KME volatility | |
---|---|
KME Average Weekly Movement | 16.4% |
Commercial Services Industry Average Movement | 5.1% |
Market Average Movement | 4.8% |
10% most volatile stocks in PL Market | 8.6% |
10% least volatile stocks in PL Market | 3.0% |
Stable Share Price: KME's share price has been volatile over the past 3 months compared to the Polish market.
Volatility Over Time: Insufficient data to determine KME's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | 32 | Maksym Wojcik | kancelaria-medius.pl |
Kancelaria Medius S.A. engages in debt portfolios management in Poland, Spain, Mexico, and the Czech Republic. The company is involved in the acquisition and management of short-term consumer receivables, and management of securitized receivables. It offers receivables purchase on its own account and servicing receivables on commission.
Kancelaria Medius S.A. Fundamentals Summary
KME fundamental statistics | |
---|---|
Market cap | zł5.07m |
Earnings (TTM) | -zł4.80m |
Revenue (TTM) | zł13.08m |
0.4x
P/S Ratio-1.1x
P/E RatioIs KME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
KME income statement (TTM) | |
---|---|
Revenue | zł13.08m |
Cost of Revenue | zł5.05m |
Gross Profit | zł8.02m |
Other Expenses | zł12.83m |
Earnings | -zł4.80m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.33 |
Gross Margin | 61.35% |
Net Profit Margin | -36.74% |
Debt/Equity Ratio | -129.4% |
How did KME perform over the long term?
See historical performance and comparison